Prevalence of autoantibodies in type 1 diabetes patients and its association with the clinical presentation - UAE Eastern Region experience

J Pediatr Endocrinol Metab. 2014 Nov;27(11-12):1157-9. doi: 10.1515/jpem-2013-0430.

Abstract

Background: Positive autoantibodies and its association with the clinical course of type 1 diabetes mellitus (T1DM) have been reported worldwide, however, no such data have been reported in United Arab Emirates population.

Objectives: To study the prevalence of positive autoantibodies in T1DM pediatric patients and its association with the clinical presentation.

Methods: Descriptive retrospective chart review of all new cases of pediatric T1DM at Tawam Hospital. Electronic patient records accessed to obtain data.

Results: 61 patients were identified. 88%±8.1 had at least 1 positive antibody and 82% of all patients were positive for anti-glutamic acid decarboxylase (GAD). While comparing the group of any positive antibody (n=54) with the group of all negative antibodies (n=7), a significant difference was found in the mean HbA1C (p=0.02) and nationality (p=0.03).

Conclusion: The vast majority of our T1DM pediatric patients are autoantibody positive, and anti-GAD antibodies were the most commonly detected antibodies.

MeSH terms

  • Adolescent
  • Autoantibodies / blood*
  • Child
  • Child, Preschool
  • Diabetes Mellitus, Type 1 / blood
  • Diabetes Mellitus, Type 1 / epidemiology*
  • Diabetes Mellitus, Type 1 / immunology
  • Female
  • Follow-Up Studies
  • Glutamate Decarboxylase / immunology*
  • Humans
  • Infant
  • Male
  • Prevalence
  • Prognosis
  • Retrospective Studies
  • United Arab Emirates / epidemiology

Substances

  • Autoantibodies
  • Glutamate Decarboxylase